Jamie Kasuboski

Fundador en

Avilar Therapeutics, Inc.

Health Technology

Finance

Consumer Services

Perfil

Jamie is a Vice President with OMX Ventures.
Prior to OMX Jamie developed deep experience in early-stage Biotech investing and company creation while working on the investment team at RA Capital.
In that role he served on the board of Enara Bio, Avilar Therapeutics, and Endor Therapeutics.
Before joining RA, he was a Director at Boehringer Ingelheim Venture Fund and served as a Board Director of both Tilos Therapeutics (acquired by Merck & Co.) and Rewind Therapeutics.
Education: PhD in Molecular and Cellular Biology from the University of Notre Dame and a BS in Biology with a minor in Chemistry from Hillsdale College

Cargos activos de Jamie Kasuboski

Empresas	Cargo	Inicio
ReAx Biotechnologies ReAx Biotechnologies BiotechnologyHealth Technology Engages in drug discovery activities and development of molecular therapies	Director/Miembro de la Junta	01/12/2021
Seeker Biologics, Inc. Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs	Director/Miembro de la Junta	01/09/2021
Glyphic Biotechnologies Inc Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops protein sequencing platform to enable researchers to gain novel insights into biology and disease	Director/Miembro de la Junta	01/04/2021
Chicago Biomedical Consortium	Consultor / Asesor	01/04/2022
Avilar Therapeutics, Inc. Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases	Fundador	01/11/2019
LUMA Group LUMA Group Investment ManagersFinance LUMA Group is an active manager.	Inversor de Capital Privado	-

Todos los cargos activos de Jamie Kasuboski

Antiguos cargos conocidos de Jamie Kasuboski.

Empresas	Cargo	Fin
Omx Ventures LLC Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments.	Inversor de Capital Privado	01/02/2024
Enara Bio Ltd. Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies	Director/Miembro de la Junta	01/02/2021
ReWind Therapeutics NV ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies	Director/Miembro de la Junta	01/09/2019
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░	░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░

Ver el detalle de la experiencia de Jamie Kasuboski.

Formación de Jamie Kasuboski.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jamie Kasuboski.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	13
University of Notre Dame University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hillsdale College Hillsdale College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Investment ManagersFinance Acts as Family of Funds	Finance
Tilos Therapeutics, Inc. Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease	Health Technology
ReWind Therapeutics NV ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies	Health Technology
Chicago Biomedical Consortium
Omx Ventures LLC Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments.	Finance
Avilar Therapeutics, Inc. Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases	Commercial Services
LUMA Group LUMA Group Investment ManagersFinance LUMA Group is an active manager.	Finance
Glyphic Biotechnologies Inc Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops protein sequencing platform to enable researchers to gain novel insights into biology and disease	Commercial Services
Enara Bio Ltd. Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies	Health Technology
ReAx Biotechnologies ReAx Biotechnologies BiotechnologyHealth Technology Engages in drug discovery activities and development of molecular therapies	Health Technology
Seeker Biologics, Inc. Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs	Health Technology